Axonex AI Group Limited - Class A Ordinary Shares (NQ:AXNX)

0.8001 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axonex AI Group Limited - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

Axonex AI Group Limited Announces 2-for-5 Reverse Stock Split

October 20, 2026

From Axonex AI Group Limited

Via GlobeNewswire

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

August 04, 2025

From RxSight, Inc.

Via GlobeNewswire

Axonics Reports Third Quarter 2024 Financial Results

November 07, 2024

From Axonics, Inc.

Via Business Wire

Beyond The Numbers: 7 Analysts Discuss Axonics Stock ↗

February 29, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Axonics ↗

January 09, 2024

Via Benzinga

Why Axonics Stock Soared Today ↗

January 08, 2024

The medical device maker agreed to be acquired by Boston Scientific.

Via The Motley Fool

Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia

September 26, 2024

From Axonics, Inc.

Via Business Wire

Axonics Prevails in Patent Infringement Lawsuit with Medtronic

September 18, 2024

From Axonics, Inc.

Via Business Wire

Axonics Reports Second Quarter 2024 Financial Results

August 01, 2024

From Axonics, Inc.

Via Business Wire

7 Robotics Stocks That Could Grow Your Wealth ↗

July 22, 2024

Explore robotics stocks with the potential to grow investors' wealth as the industry expands across various sectors.

Via InvestorPlace

Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

May 16, 2024

From Axonics, Inc.

Via Business Wire

AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024 ↗

April 30, 2024

AXNX stock results show that Axonics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Axonics Reports First Quarter 2024 Financial Results

April 30, 2024

From Axonics, Inc.

Via Business Wire

Boston Scientific Bucks the Medtech Slow Down and Raises Outlook

April 30, 2024

Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.

Via MarketBeat

FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' ↗

April 18, 2024

Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major...

Via Benzinga

Axonics Stockholders Approve Merger Agreement with Boston Scientific

March 22, 2024

From Axonics, Inc.

Via Business Wire

Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

March 14, 2024

From Axonics, Inc.

Via Business Wire

Axonics Responds to ITC Action by Medtronic

February 29, 2024

From Axonics, Inc.

Via Business Wire

Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

February 28, 2024

From Axonics, Inc.

Via Business Wire

AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX

February 27, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Why Medical Devices Giant Boston Scientific Shares Are Rising Today ↗

January 31, 2024

Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024.

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

January 16, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗

January 12, 2024

The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.

Via Investor's Business Daily

Topics ETFs

Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling ↗

January 11, 2024

The Nasdaq 100 closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

10 Top Stocks With a Strong Buy Rating Right Now ↗

January 09, 2024

Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch.

Via InvestorPlace

January 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

Why Is Crocs (CROX) Stock Up 20% Today? ↗

January 08, 2024

Crocs stock is heading higher on Monday with heavy trading of CROX shares after the company posted a strong outlook for 2024!

Via InvestorPlace

Why Is Axonics (AXNX) Stock Up 20% Today? ↗

January 08, 2024

Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific.

Via InvestorPlace

Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today? ↗

January 08, 2024

Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.